Authors:
Haq, IU
Ramsay, LE
Wallis, EJ
Isles, CG
Ritchie, LD
Jackson, PR
Citation: Iu. Haq et al., Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey, HEART, 86(3), 2001, pp. 289-295
Authors:
Burton, CD
Hamilton, KES
Isles, CG
Norrie, J
Citation: Cd. Burton et al., Warfarin for nonvalvular atrial fibrillation in primary care - another example of the age paradox?, J CARD RISK, 8(5), 2001, pp. 307-309
Citation: Cm. Stirling et Cg. Isles, Rhabdomyolysis due to simvastatin in a transplant patient: are some statins safer than others?, NEPH DIAL T, 16(4), 2001, pp. 873-874
Citation: Cg. Isles et Jr. Paterson, Identifying patients at risk for coronary heart disease: implications fromtrials of lipid-lowering drug therapy, QJM-MON J A, 93(9), 2000, pp. 567-574
Authors:
Isles, CG
Ritchie, LD
Murchie, P
Norrie, J
Citation: Cg. Isles et al., Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods, BR MED J, 320(7236), 2000, pp. 690-691
Citation: Cg. Isles et al., Management of renovascular disease: a review of renal artery stenting in ten studies, QJM-MON J A, 92(3), 1999, pp. 159-167
Authors:
Lever, AF
Beevers, DG
Hole, DJ
Isles, CG
Meredith, PA
Murray, LS
McInnes, GT
Reid, JL
Citation: Af. Lever et al., Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?, CLIN EXP HY, 21(5-6), 1999, pp. 553-562
Citation: Cg. Isles et Nre. Kitchin, A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension, J HUM HYPER, 13(1), 1999, pp. 69-73
Authors:
Packard, CJ
Shepherd, J
Macfarlane, PW
Cobbe, SM
Ford, I
Isles, CG
Citation: Cj. Packard et al., Overlap analysis of the west of Scotland coronary prevention study (WOSCOPS) - Response, CIRCULATION, 100(6), 1999, pp. 686-686